1 – 5 of 29
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer
2024) In Molecular Oncology(
- Contribution to journal › Article
- 2021
-
Mark
Protein signature predicts response to neoadjuvant treatment with chemotherapy and bevacizumab in HER2-negative breast cancers
(
- Contribution to journal › Article
-
Mark
Mendelian randomisation study of smoking exposure in relation to breast cancer risk
(
- Contribution to journal › Article
- 2019
-
Mark
Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation
(
- Contribution to journal › Article
-
Mark
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment
(
- Contribution to journal › Article